Similar articles

• Chemotactic factor inactivation by stimulated human neutrophils mediated by myeloperoxidase-catalyzed methionine oxidation.

  Clark RA, Szot S. Clark RA, et al. J Immunol. 1982 Apr;128(4):1507-13. J Immunol. 1982. PMID: 6278020
• Chemotactic deactivation of human neutrophils: relationship to loss of cytotaxin receptor function and temporal nature of the phenomenon.

  Nelson RD, Fiegel VD, Herron MJ, Simmons RL. Nelson RD, et al. J Reticuloendothel Soc. 1980 Sep;28(3):285-94. J Reticuloendothel Soc. 1980. PMID: 7411541 No abstract available.
• Phagocytosis-induced modulation of human neutrophil chemotaxis receptors.

  Lane TA, Lamkin GC, Windle BE. Lane TA, et al. Blood. 1981 Aug;58(2):228-36. Blood. 1981. PMID: 6264995 No abstract available.
• Periodontal diseases and impaired neutrophil function.

  Van Dyke TE, Levine MJ, Al-Hashimi I, Genco RJ. Van Dyke TE, et al. J Periodontal Res. 1982 Sep;17(5):492-4. doi: 10.1111/j.1600-0765.1982.tb02036.x. J Periodontal Res. 1982. PMID: 6218280 No abstract available.
• On the relationship between formylmethionyl-leucyl-phenylalanine stimulation of arachidonyl phosphatidylinositol turnover and lysosomal enzyme secretion by rabbit neutrophils.

  Rubin RP, Sink LE, Freer RJ. Rubin RP, et al. Mol Pharmacol. 1981 Jan;19(1):31-7. Mol Pharmacol. 1981. PMID: 7207461 No abstract available.